Literature DB >> 2856515

N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite.

J Uetrecht1, N Zahid.   

Abstract

Several types of phenytoin toxicity appear to involve leukocytes. We had previously demonstrated that other drugs were metabolized to reactive metabolites by activated neutrophils and monocytes or the combination of myeloperoxidase (MPO) and hydrogen peroxide. In this study we found that phenytoin was chlorinated by MPO/H2O2/Cl- to N,N'-dichlorophenytoin which is chemically reactive. Failure to demonstrate that activated neutrophils also formed N,N'-dichlorophenytoin appeared to be due to the rapid reaction of N,N'-dichlorophenytoin with neutrophils. We were able to demonstrate that phenytoin covalently bound to albumin in the presence of MPO/H2O2/Cl- and to neutrophils, but only if the cells were activated. Such activation leads to the release of MPO and the generation of H2O2. We, therefore, speculate that the toxicity of phenytoin may be due to the formation of N,N'-dichlorophenytoin by activated neutrophils or monocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2856515     DOI: 10.1021/tx00003a004

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  5 in total

Review 1.  Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.

Authors:  J P Uetrecht
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

Review 2.  Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.

Authors:  J P Uetrecht
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

3.  Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro.

Authors:  R J Riley; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

4.  A simple and expedient method for the preparation of N-chlorohydantoins.

Authors:  Daniel C Whitehead; Richard J Staples; Babak Borhan
Journal:  Tetrahedron Lett       Date:  2009-02-11       Impact factor: 2.415

Review 5.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.